Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Molecular features assisting in diagnosis, surgery, and treatment decision making in low-grade gliomas.

Neurosurgical focus - 1 Mar 2015

Chen Ricky, Ravindra Vijay M, Cohen Adam L, Jensen Randy L, Salzman Karen L, Prescot Andrew P, Colman Howard

Abstract excerpt

The preferred management of suspected low-grade gliomas (LGGs) has been disputed, and the implications of molecular changes for medical and surgical management of LGGs are important to consider. Current strategies that make use of molecular markers and imaging techniques and therapeutic considerations offer additional options for management of LGGs. Mutations in the isocitrate dehydrogenase 1 and 2 (IDH1 and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Brain Neoplasms
Share to Decision Making

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to DNA Modification Methylases

Share to DNA Repair Enzymes

Share to Epigenomics

Share to Glioma

Share to Isocitrate Dehydrogenase

Share to Neurosurgical Procedures

Source

Identifiers

PMID: 25727224
DOI: 10.3171/2015.1.FOCUS14745

Genes

IDH1
IDH2
MGMT

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Molecular features assisting in diagnosis, surgery, and treatment decision making in low-grade gliomas.PMID 25727224Read ↗

Advances in molecular and imaging biomarkers in lower-grade gliomas.Semantic proximity Read ↗

Lower Grade Gliomas.Semantic proximity Read ↗

Recent developments and future directions in adult lower-grade gliomas: Society for Neuro-Oncology (SNO) and European Association of Neuro-Oncology (EANO) consensusSemantic proximity Read ↗

IDH1 and IDH2 mutations in gliomas.Semantic proximity Read ↗

Molecular biology of high-grade gliomas: what should the clinician know?Semantic proximity Read ↗

State of the Art in Low-Grade Glioma Management: Insights From Isocitrate Dehydrogenase and Beyond.Semantic proximity Read ↗

The Evolving Molecular Landscape of High-Grade Gliomas.Semantic proximity Read ↗

The clinical use of IDH1 and IDH2 mutations in gliomasSemantic proximity Read ↗

Isocitrate dehydrogenase status and molecular subclasses of glioma and glioblastomaSemantic proximity Read ↗

Molecular genetics of low-grade gliomas: genomic alterations guiding diagnosis and therapeutic intervention. 11th annual Frye-Halloran Brain Tumor Symposium.Semantic proximity Read ↗

Management for Different Glioma Subtypes: Are All Low-Grade Gliomas Created Equal?Semantic proximity Read ↗

Imaging scoring systems for preoperative molecular diagnoses of lower-grade gliomas.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.